Contact this trialFirst, we need to learn more about you.
MEK Inhibitor
Trametinib for Histiocytosis
Recruiting1 awardPhase 2
Fort Worth, Texas
This trial aims to test if trametinib, a specific type of treatment, is safe and works well in treating Langerhans Cell Histiocytosis (LCH) in children
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service